Shang-Hung Chen - Search Results

Year	Number of Results
2005	1
2012	1
2013	3
2014	2
2015	2
2016	1
2017	1
2018	2
2019	6
2020	4
2021	8
2022	8
2023	7
2024	2

1

Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.

Cheng SM, Su YY, Chiang NJ, Wang CJ, Chao YJ, Huang CJ, Tsai HJ, Chen SH, Chang CY, Tsai CR, Li YJ, Yen CJ, Chuang SC, Chang JS, Shan YS, Hwang DY, Chen LT. Cheng SM, et al. Among authors: chen sh. J Biomed Sci. 2024 Feb 13;31(1):21. doi: 10.1186/s12929-024-01008-7. J Biomed Sci. 2024. PMID: 38350919 Free PMC article.

2

Topical Antibiotic Prophylaxis for Preventing Surgical Site Infections of Clean Wounds: A Systematic Review and Meta-Analysis.

Lin WL, Wu LM, Nguyen TH, Lin YH, Chen CJ, Huang WT, Guo HR, Chen YH, Chuang CH, Chang PC, Hung HK, Chen SH. Lin WL, et al. Among authors: chen sh. Surg Infect (Larchmt). 2024 Feb;25(1):32-38. doi: 10.1089/sur.2023.182. Epub 2023 Dec 19. Surg Infect (Larchmt). 2024. PMID: 38112687

3

The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study.

Tsai HL, Lin CC, Sung YC, Chen SH, Chen LT, Jiang JK, Wang JY. Tsai HL, et al. Among authors: chen sh. Br J Cancer. 2023 Oct;129(6):947-955. doi: 10.1038/s41416-023-02366-z. Epub 2023 Jul 24. Br J Cancer. 2023. PMID: 37488448 Free PMC article.

4

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.

Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.

5

Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer.

Lee CT, Chu CA, Wang YM, Wang YW, Chen YL, Ho CL, Yeh YM, Lin PC, Lin BW, Chen PC, Chen SH, Chan RH, Chang C, Chow NH. Lee CT, et al. Among authors: chen sh. Mol Carcinog. 2023 Jul;62(7):951-962. doi: 10.1002/mc.23537. Epub 2023 Apr 4. Mol Carcinog. 2023. PMID: 37014154

6

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.

Chiang HC, Lee YC, Chang TT, Lin YJ, Wu HT, Wang CT, Chen CY, Chen PJ, Hsieh MT, Lin SH, Chen SH, Chuang CH, Wu IC, Hong TC, Wu JS, Han MZ, Chen WT, Chiang CM, Hung KK, Kuo HY. Chiang HC, et al. Among authors: chen sh. Cancers (Basel). 2023 Jan 30;15(3):854. doi: 10.3390/cancers15030854. Cancers (Basel). 2023. PMID: 36765812 Free PMC article.

7

MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.

Hsiao SY, Weng SM, Hsiao JR, Wu YY, Wu JE, Tung CH, Shen WL, Sun SF, Huang WT, Lin CY, Chen SH, Hong TM, Chen YL, Chang JY. Hsiao SY, et al. Among authors: chen sh. J Exp Clin Cancer Res. 2023 Feb 3;42(1):40. doi: 10.1186/s13046-023-02597-1. J Exp Clin Cancer Res. 2023. PMID: 36737832 Free PMC article.

8

HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study.

Chen PC, Yeh YM, Chu CT, Su PF, Chiu PH, Lin BW, Chen SH, Lin PC, Lee CT, Chen HHW, Chen CC. Chen PC, et al. Among authors: chen sh. Eur J Cancer. 2023 Mar;181:62-69. doi: 10.1016/j.ejca.2022.12.019. Epub 2022 Dec 27. Eur J Cancer. 2023. PMID: 36640475

9

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma.

Kuo HY, Han MZ, Liao CH, Lin YJ, Wang CT, Chen SH, Chang TT, Chen PJ, Lin SH, Chen CY, Chuang CH, Wu IC, Wu JS, Hong TC, Hsieh MT, Lee YC, Wu HT, Tsai HM. Kuo HY, et al. Among authors: chen sh. Pharmaceutics. 2022 Oct 23;14(11):2263. doi: 10.3390/pharmaceutics14112263. Pharmaceutics. 2022. PMID: 36365082 Free PMC article.

10

PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer-Its Clinical and Biological Significance in Immune Microenvironment.

Chung BS, Liao IC, Lin PC, Wu SY, Kang JW, Lin BW, Chen PC, Chan RH, Lee CT, Shen MR, Chen SH, Yeh YM. Chung BS, et al. Among authors: chen sh. Int J Mol Sci. 2022 Oct 31;23(21):13277. doi: 10.3390/ijms232113277. Int J Mol Sci. 2022. PMID: 36362062 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year